Australian Research on Rapid Blood Tests for Heart Attack Diagnosis

Introduction to the Study

Australian researchers have explored a novel system of rapid blood tests designed to assist doctors in making timely decisions regarding patient care for heart attacks. Each year, approximately 30,000 patients in Australia seek emergency care due to chest pain, a common indicator of potential heart attacks. Determining which patients require hospitalization and which can be safely discharged is crucial for healthcare professionals.

The Role of Troponin T in Diagnosis

A highly sensitive blood test measuring Troponin T, a protein released by cardiac muscle upon injury, plays a significant role in diagnosing heart attacks. Elevated Troponin T levels in the bloodstream, when interpreted alongside other clinical tests, can confirm a heart attack diagnosis.

Study Design and Methodology

Overview of the Research

Researchers from Adelaide conducted a comprehensive study to optimize the use of high sensitivity Troponin T blood tests. Their goal was to accurately differentiate between patients experiencing heart attacks and those who could be sent home safely. The findings were presented at the European Society of Cardiology World Conference in Paris on September 4, 2019.

Patient Testing Procedure

From August 2015 to April 2019, over 3,300 patients suspected of having a heart attack were randomly assigned to two groups. One group received Troponin T blood tests upon admission and were retested one hour later, while the other group was tested at admission and retested three hours later. All patients underwent standard emergency department assessments, including clinical examinations and ECGs. Their health outcomes were monitored during their hospital visits and for 30 days thereafter.

Key Findings and Outcomes

Impact of One-Hour Retesting

Patients in the one-hour retesting group spent, on average, one hour less in the emergency department compared to those in the three-hour group. Additionally, the hospitalization rate was lower in the one-hour group, with 33.2% requiring admission versus 45.5% in the three-hour group. Notably, there were no significant differences in healthcare outcomes between the two groups.

Conclusions from the Study

The researchers concluded that the one-hour testing protocol utilizing high sensitivity Troponin T blood tests effectively identifies heart attack patients. This approach facilitates quicker decision-making, reduced emergency department wait times, and fewer unnecessary hospital admissions. Professor Derek Chew, the study’s lead author, emphasized the broader benefits of this system for emergency department efficiency.

Future Directions

Professor Chew expressed hope that the integration of artificial intelligence could further enhance decision-making processes for doctors. An electronic system capable of accurately estimating heart attack risks based on a comprehensive database of blood test results could provide significant support for clinical judgments.

References

1. Chew DP, Lambrakis K, Blyth A, et al. A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the rapid assessment of possible ACS in the emergency department with high sensitivity troponin T (RAPID-TnT) study. Circulation Doi:10.1161/CirculationJA.119.042891.
2. Flinders University, Press release 3 September 2019. “World-first cardio trial shows shorter wait times and admissions” https://www.eurekalert.org/pub_releases/2019-09/fu-wct090119.php

Written by Julie McShane, MA MB BS.